Understanding how certain RNA modifications lead to leukemia
Mechanisms of Leukemogenesis in AMKL
This study is looking into how a specific change in RNA, called m6A, affects the development of acute megakaryoblastic leukemia (AMKL) by examining a special protein linked to the disease, to help us understand what causes this type of cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10873964 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind acute megakaryoblastic leukemia (AMKL) by focusing on a specific RNA modification known as N6-methyladenosine (m6A). The study aims to uncover how alterations in the proteins that add or remove this modification contribute to the development of leukemia. By examining the fusion protein RBM15-MKL1, which is linked to AMKL, the researchers will explore its role in changing RNA methylation patterns and gene expression. This work involves advanced genome-wide studies to better understand the molecular interactions that drive this type of cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute megakaryoblastic leukemia or those with related hematological conditions.
Not a fit: Patients with solid tumors or other non-hematological cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies for patients with AMKL and potentially other forms of leukemia.
How similar studies have performed: Previous research has shown promising results in understanding RNA modifications in cancer, suggesting that this approach could yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Krause, Diane S — Yale University
- Study coordinator: Krause, Diane S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.